Clinical Trials List
Protocol NumberCVM-006
2021-09-24 - 2022-12-28
Phase I
Recruiting2
-
Trial Applicant
TaiRx, Inc.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Po-Lan Su Division of Thoracic Medicine
- Yu-Min Yeh Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Chien-Chung Lin Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
0 participants
